Recommendations for management of patients with neuroendocrine liver metastases

Andrea Frilling, Irvin M. Modlin*, Mark Kidd, Christopher Russell, Stefan Breitenstein, Riad Salem, Dik Kwekkeboom, Wan yee Lau, Catherine Klersy, Valerie Vilgrain, Brian Davidson, Mark Siegler, Martyn Caplin, Enrico Solcia, Richard Schilsky

*Corresponding author for this work

Research output: Contribution to journalReview article

209 Citations (Scopus)

Abstract

Many management strategies exist for neuroendocrine liver metastases. These strategies range from surgery to ablation with various interventional radiology procedures, and include both regional and systemic therapy with diverse biological, cytotoxic, or targeted agents. A paucity of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of many publications detailing management. This Review represents the views from an international conference, for which 15 expert working groups prepared evidence-based assessments addressing specific questions, and from which an independent jury derived final recommendations. The aim of the conference was to review the existing approaches to neuroendocrine liver metastases, assess the evidence on which management decisions were based, develop internationally acceptable recommendations for clinical practice (when evidence was available), and make recommendations for clinical and research endeavours. This report represents the final clinical statements and proposals for future research.

Original languageEnglish (US)
JournalThe Lancet Oncology
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Neoplasm Metastasis
Interventional Radiology
Liver
Publications
Research
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Frilling, A., Modlin, I. M., Kidd, M., Russell, C., Breitenstein, S., Salem, R., ... Schilsky, R. (2014). Recommendations for management of patients with neuroendocrine liver metastases. The Lancet Oncology, 15(1). https://doi.org/10.1016/S1470-2045(13)70362-0
Frilling, Andrea ; Modlin, Irvin M. ; Kidd, Mark ; Russell, Christopher ; Breitenstein, Stefan ; Salem, Riad ; Kwekkeboom, Dik ; Lau, Wan yee ; Klersy, Catherine ; Vilgrain, Valerie ; Davidson, Brian ; Siegler, Mark ; Caplin, Martyn ; Solcia, Enrico ; Schilsky, Richard. / Recommendations for management of patients with neuroendocrine liver metastases. In: The Lancet Oncology. 2014 ; Vol. 15, No. 1.
@article{b086d9c688034fa39ec18cdf0d486ea6,
title = "Recommendations for management of patients with neuroendocrine liver metastases",
abstract = "Many management strategies exist for neuroendocrine liver metastases. These strategies range from surgery to ablation with various interventional radiology procedures, and include both regional and systemic therapy with diverse biological, cytotoxic, or targeted agents. A paucity of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of many publications detailing management. This Review represents the views from an international conference, for which 15 expert working groups prepared evidence-based assessments addressing specific questions, and from which an independent jury derived final recommendations. The aim of the conference was to review the existing approaches to neuroendocrine liver metastases, assess the evidence on which management decisions were based, develop internationally acceptable recommendations for clinical practice (when evidence was available), and make recommendations for clinical and research endeavours. This report represents the final clinical statements and proposals for future research.",
author = "Andrea Frilling and Modlin, {Irvin M.} and Mark Kidd and Christopher Russell and Stefan Breitenstein and Riad Salem and Dik Kwekkeboom and Lau, {Wan yee} and Catherine Klersy and Valerie Vilgrain and Brian Davidson and Mark Siegler and Martyn Caplin and Enrico Solcia and Richard Schilsky",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/S1470-2045(13)70362-0",
language = "English (US)",
volume = "15",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "1",

}

Frilling, A, Modlin, IM, Kidd, M, Russell, C, Breitenstein, S, Salem, R, Kwekkeboom, D, Lau, WY, Klersy, C, Vilgrain, V, Davidson, B, Siegler, M, Caplin, M, Solcia, E & Schilsky, R 2014, 'Recommendations for management of patients with neuroendocrine liver metastases', The Lancet Oncology, vol. 15, no. 1. https://doi.org/10.1016/S1470-2045(13)70362-0

Recommendations for management of patients with neuroendocrine liver metastases. / Frilling, Andrea; Modlin, Irvin M.; Kidd, Mark; Russell, Christopher; Breitenstein, Stefan; Salem, Riad; Kwekkeboom, Dik; Lau, Wan yee; Klersy, Catherine; Vilgrain, Valerie; Davidson, Brian; Siegler, Mark; Caplin, Martyn; Solcia, Enrico; Schilsky, Richard.

In: The Lancet Oncology, Vol. 15, No. 1, 01.01.2014.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Recommendations for management of patients with neuroendocrine liver metastases

AU - Frilling, Andrea

AU - Modlin, Irvin M.

AU - Kidd, Mark

AU - Russell, Christopher

AU - Breitenstein, Stefan

AU - Salem, Riad

AU - Kwekkeboom, Dik

AU - Lau, Wan yee

AU - Klersy, Catherine

AU - Vilgrain, Valerie

AU - Davidson, Brian

AU - Siegler, Mark

AU - Caplin, Martyn

AU - Solcia, Enrico

AU - Schilsky, Richard

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Many management strategies exist for neuroendocrine liver metastases. These strategies range from surgery to ablation with various interventional radiology procedures, and include both regional and systemic therapy with diverse biological, cytotoxic, or targeted agents. A paucity of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of many publications detailing management. This Review represents the views from an international conference, for which 15 expert working groups prepared evidence-based assessments addressing specific questions, and from which an independent jury derived final recommendations. The aim of the conference was to review the existing approaches to neuroendocrine liver metastases, assess the evidence on which management decisions were based, develop internationally acceptable recommendations for clinical practice (when evidence was available), and make recommendations for clinical and research endeavours. This report represents the final clinical statements and proposals for future research.

AB - Many management strategies exist for neuroendocrine liver metastases. These strategies range from surgery to ablation with various interventional radiology procedures, and include both regional and systemic therapy with diverse biological, cytotoxic, or targeted agents. A paucity of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of many publications detailing management. This Review represents the views from an international conference, for which 15 expert working groups prepared evidence-based assessments addressing specific questions, and from which an independent jury derived final recommendations. The aim of the conference was to review the existing approaches to neuroendocrine liver metastases, assess the evidence on which management decisions were based, develop internationally acceptable recommendations for clinical practice (when evidence was available), and make recommendations for clinical and research endeavours. This report represents the final clinical statements and proposals for future research.

UR - http://www.scopus.com/inward/record.url?scp=84891369262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891369262&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(13)70362-0

DO - 10.1016/S1470-2045(13)70362-0

M3 - Review article

AN - SCOPUS:84891369262

VL - 15

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 1

ER -